Publications

Abid, Q; Best Rocha, A; Larsen, CP; Schulert, G; Marsh, R; Yasin, S; Patty-Resk, C; Valentini, RP; Adams, M; Baracco, R. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI). American Journal of Kidney Diseases. 2020; 75:287-290.

Chung, H; Wangler, MF; Marcogliese, PC; Jo, J; Ravenscroft, TA; Zuo, Z; Duraine, L; Sadeghzadeh, S; Li-Kroeger, D; Schmidt, RE; et al. Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms. Neuron. 2020; 106:589-606.e6.

de Jesus, AA; Hou, Y; Brooks, S; Malle, L; Biancotto, A; Huang, Y; Calvo, KR; Marrero, B; Moir, S; Oler, AJ; et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. Journal of Clinical Investigation. 2020; 130:1669-1682.

Ferrara, G; Giani, T; Lieberman, SM; Kremer, C; Hong, S; Indolfi, G; Schulert, G; Cron, RQ; Mannion, ML; Lapidus, S; et al. Alagille Syndrome and Chronic Arthritis: An International Case Series. The Journal of Pediatrics. 2020; 218:228-230.e1.

Huang, B; Qiu, T; Chen, C; Neace, A; Zhang, Y; Yue, X; Zahner, J; Adams, M; Seid, M; Lovell, D; et al. Comparative Effectiveness Research Using Electronic Health Records Data: Ensure Data Quality. 2020.

Huang, B; Qiu, T; Chen, C; Neace, A; Zhang, Y; Yue, XM; Zahner, J; Adams, M; Seid, M; Lovell, D; et al. Comparative Effectiveness Research using Electronic Health Records Data: Ensure Data Quality. Sage. 2020.

Huang, B; Qiu, T; Chen, C; Zhang, Y; Seid, M; Lovell, D; Brunner, HI; Morgan, EM; PCATS, . Timing matters: Real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis. RMD Open. 2020; 6:e001091-e001091.

Lee, PY; Schulert, GS; Canna, SW; Huang, Y; Sundel, J; Li, Y; Hoyt, KJ; Blaustein, RB; Wactor, A; Do, T; et al. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 2020; 79:225-231.

Locatelli, F; Jordan, MB; Allen, C; Cesaro, S; Rizzari, C; Rao, A; Degar, B; Garrington, TP; Sevilla, J; Putti, M; et al. Emapalumab in children with primary hemophagocytic lymphohistiocytosis. The New England journal of medicine. 2020; 382:1811-1822.

Reighard, SD; Cranert, SA; Rangel, KM; Ali, A; Gyurova, IE; de la Cruz-Lynch, AT; Tuazon, JA; Khodoun, MV; Kottyan, LC; Smith, DF; et al. Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. 2020; 1:100003-100003.

Ringold, S; Schrandt, S; Creek, EL; Beukelman, T; Angeles-Han, ST; Lovell, DJ. Reply. Arthritis and Rheumatology. 2020; 72:1040-1041.

Rodriguez-Smith, J; Yeh, S; Angeles-Han, ST. Improving quick and accurate diagnosis of childhood JIA-uveitis from a pediatric rheumatology perspective. Expert Review of Ophthalmology. 2020; 15:101-109.

Schulert, GS. Can tocilizumab calm the cytokine storm of COVID-19?. 2020.

Schulert, GS; Cron, RQ. The genetics of macrophage activation syndrome. Genes and Immunity. 2020; 21:169-181.

Verweyen, E; Holzinger, D; Weinhage, T; Hinze, C; Wittkowski, H; Pickkers, P; Albeituni, S; Verbist, K; Nichols, KE; Schulert, G; et al. Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance. American Journal of Respiratory and Critical Care Medicine. 2020; 201:526-539.

Yasin, S; Fall, N; Brown, RA; Henderlight, M; Canna, SW; Girard-Guyonvarc'h, C; Gabay, C; Grom, AA; Schulert, GS. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Rheumatology. 2020; 59:361-366.

Yasin, S; Solomon, K; Canna, SW; Girard-Guyonvarc'h, C; Gabay, C; Schiffrin, E; Sleight, A; Grom, AA; Schulert, GS. IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome. Rheumatology. 2020; 59:442-445.